MA54949A - Biomarqueurs de la leucoencéphalopathie multifocale progressive - Google Patents
Biomarqueurs de la leucoencéphalopathie multifocale progressiveInfo
- Publication number
- MA54949A MA54949A MA054949A MA54949A MA54949A MA 54949 A MA54949 A MA 54949A MA 054949 A MA054949 A MA 054949A MA 54949 A MA54949 A MA 54949A MA 54949 A MA54949 A MA 54949A
- Authority
- MA
- Morocco
- Prior art keywords
- biomarkers
- progressive multifocal
- multifocal leukoencephalopathy
- leukoencephalopathy
- progressive
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title 1
- 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962804701P | 2019-02-12 | 2019-02-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54949A true MA54949A (fr) | 2021-12-22 |
Family
ID=69960699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054949A MA54949A (fr) | 2019-02-12 | 2020-02-11 | Biomarqueurs de la leucoencéphalopathie multifocale progressive |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220128578A1 (fr) |
| EP (1) | EP3924739A1 (fr) |
| MA (1) | MA54949A (fr) |
| WO (1) | WO2020167715A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019147960A1 (fr) | 2018-01-25 | 2019-08-01 | Biogen Ma Inc. | Méthodes de traitement de l'amyotrophie musculaire |
| MX2021006548A (es) | 2018-12-06 | 2021-09-21 | Biogen Ma Inc | Proteina de neurofilamento para guiar la intervencion terapeutica en la esclerosis lateral amiotrofica. |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5156840A (en) | 1982-03-09 | 1992-10-20 | Cytogen Corporation | Amine-containing porphyrin derivatives |
| EP0088994B1 (fr) | 1982-03-15 | 1991-06-19 | Schering Corporation | ADN hybride, composition liante produite à l'aide de celui-ci et procédés pour la mise en oeuvre |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4582789A (en) | 1984-03-21 | 1986-04-15 | Cetus Corporation | Process for labeling nucleic acids using psoralen derivatives |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (fr) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Récepteurs chimériques par liaison et expression de l'ADN |
| US4563417A (en) | 1984-08-31 | 1986-01-07 | Miles Laboratories, Inc. | Nucleic acid hybridization assay employing antibodies to intercalation complexes |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| US5057313A (en) | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| AU1248292A (en) | 1990-12-06 | 1992-07-08 | Affymax Technologies N.V. | Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides |
| US6027880A (en) | 1995-08-02 | 2000-02-22 | Affymetrix, Inc. | Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis |
| US6156501A (en) | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
| WO1997046313A1 (fr) | 1996-06-07 | 1997-12-11 | Eos Biotechnology, Inc. | Nouveaux reseaux d'oligonucleotides lineaires immobilises |
| US7101663B2 (en) | 2001-03-02 | 2006-09-05 | University of Pittsburgh—of the Commonwealth System of Higher Education | PCR method |
| WO2002085926A2 (fr) | 2001-04-19 | 2002-10-31 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Procede de production de series d'anticorps stables regenerables |
| US6812341B1 (en) | 2001-05-11 | 2004-11-02 | Ambion, Inc. | High efficiency mRNA isolation methods and compositions |
| US20030013208A1 (en) | 2001-07-13 | 2003-01-16 | Milagen, Inc. | Information enhanced antibody arrays |
| US7252976B2 (en) | 2002-08-28 | 2007-08-07 | Board Of Regents The University Of Texas System | Quantitative RT-PCR to AC133 to diagnose cancer and monitor angiogenic activity in a cell sample |
| IT1395574B1 (it) | 2009-09-14 | 2012-10-16 | Guala Dispensing Spa | Dispositivo di erogazione |
-
2020
- 2020-02-11 MA MA054949A patent/MA54949A/fr unknown
- 2020-02-11 EP EP20714020.3A patent/EP3924739A1/fr active Pending
- 2020-02-11 US US17/429,767 patent/US20220128578A1/en active Pending
- 2020-02-11 WO PCT/US2020/017600 patent/WO2020167715A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020167715A1 (fr) | 2020-08-20 |
| EP3924739A1 (fr) | 2021-12-22 |
| US20220128578A1 (en) | 2022-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE102020112518B8 (de) | Toner | |
| EP3776444A4 (fr) | Prédiction de défaillance de tuyau | |
| EP3513340C0 (fr) | Biomarqueurs numériques pour la sep progressive | |
| EP3506912A4 (fr) | Micro-arn servant de biomarqueurs de l'endométriose | |
| EP4211690A4 (fr) | Prédicteur de métastases | |
| EP3311158A4 (fr) | Paires de biomarqueurs permettant de prédire une naissance prématurée | |
| PT4028669T (pt) | Conjunto de suspensão | |
| IL289197A (en) | 2-hydroxycycloalkane-1-carbamoyl derivatives | |
| EP3580871C0 (fr) | Signalisation de ressources pour un pucch | |
| EP3655545C0 (fr) | Biomarqueurs d'anévrisme intracrânien | |
| EP3685169A4 (fr) | Procédé de détection de protéines de l'inflammasome à titre de biomarqueurs de troubles neurologiques | |
| EP3857231C0 (fr) | Quantification d'analytes | |
| GB201911947D0 (en) | Miscarriage biomarkers | |
| EP3937487C0 (fr) | Prédiction de canal alpha | |
| EP3959390A4 (fr) | Raidisseur pour éléments de construction | |
| MA54949A (fr) | Biomarqueurs de la leucoencéphalopathie multifocale progressive | |
| EP3963787C0 (fr) | Conception d'espace de recherche pour opérations sur wb nr-u | |
| DK3688468T3 (da) | Inflammatoriske biomarkører til forudsigelse af modtageligheden for fgf-18 forbindelse | |
| GB202014190D0 (en) | Biomarkers | |
| EP3928578C0 (fr) | Configuration de ressources concernant le nb-ido | |
| EP4330667A4 (fr) | Biomarqueurs de maladies neurodégénératives | |
| GB202112831D0 (en) | Biomarker | |
| EP4083627A4 (fr) | Biomarqueur de pronostic du cancer | |
| IT201700122785A1 (it) | Sospensioni non acquose | |
| EP4316083A4 (fr) | Comptage de ressources pour signaux de référence |